James David Clark Sells 7,513 Shares of CVS Health Co. (NYSE:CVS) Stock

CVS Health Co. (NYSE:CVS) SVP James David Clark sold 7,513 shares of the stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the sale, the senior vice president now directly owns 8,394 shares of the company’s stock, valued at $556,941.90. The trade was a 47.23 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

CVS Health Stock Up 1.7 %

CVS opened at $66.34 on Friday. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The stock’s fifty day simple moving average is $56.42 and its 200 day simple moving average is $56.76. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The stock has a market cap of $83.64 billion, a PE ratio of 18.12, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. As a group, research analysts expect that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.01%. CVS Health’s dividend payout ratio (DPR) is 72.68%.

Wall Street Analyst Weigh In

CVS has been the subject of several analyst reports. StockNews.com upgraded shares of CVS Health from a “sell” rating to a “hold” rating in a research note on Thursday, February 13th. Wolfe Research upped their target price on shares of CVS Health from 67.00 to 70.00 and gave the company an “overweight” rating in a research note on Tuesday, February 11th. Leerink Partnrs upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 12th. Truist Financial increased their price objective on shares of CVS Health from $60.00 to $76.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Finally, Royal Bank of Canada reduced their price objective on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research note on Friday, November 15th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $69.83.

Institutional Investors Weigh In On CVS Health

Hedge funds have recently added to or reduced their stakes in the business. United Advisor Group LLC bought a new stake in shares of CVS Health during the 3rd quarter worth $206,000. M&G PLC grew its holdings in CVS Health by 2.1% during the 3rd quarter. M&G PLC now owns 909,675 shares of the pharmacy operator’s stock valued at $57,310,000 after buying an additional 18,955 shares in the last quarter. Poplar Forest Capital LLC grew its holdings in shares of CVS Health by 27.1% during the third quarter. Poplar Forest Capital LLC now owns 486,074 shares of the pharmacy operator’s stock worth $30,564,000 after purchasing an additional 103,602 shares in the last quarter. WoodTrust Financial Corp purchased a new position in shares of CVS Health during the third quarter worth about $231,000. Finally, Montecito Bank & Trust lifted its position in CVS Health by 22.7% in the 3rd quarter. Montecito Bank & Trust now owns 17,190 shares of the pharmacy operator’s stock worth $1,081,000 after buying an additional 3,178 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.